Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label Dose-titration Study of the Tolerability and Efficacy of Cinacalcet to Treat Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia

NCT01748812 is registered in ClinicalTrials.gov with National Institute of Dental and Craniofacial Research (NIDCR) as lead sponsor.

NCT NCT01748812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01748812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label Dose-titration Study of the Tolerability and Efficacy of Cinacalcet to Treat Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia
Lead sponsor
National Institute of Dental and Craniofacial Research (NIDCR)
Phase
Phase 1
Overall status
Terminated
Start date
November 16, 2012
Completion date
December 31, 2016
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteomalacia